...
首页> 外文期刊>Acta medica Iranica. >Frequent Novel Variations Within MSH2 and MLH1 Genes in a Subset of Iranian Families With Hereditary Non-Polyposis Colorectal Cancer
【24h】

Frequent Novel Variations Within MSH2 and MLH1 Genes in a Subset of Iranian Families With Hereditary Non-Polyposis Colorectal Cancer

机译:在伊朗家族的子集中频繁新的MSH2和MLH1基因的变化,具有遗传性非息肉结直肠癌

获取原文

摘要

Hereditary non-polyposis colorectal cancer (HNPCC) is the most frequent autosomal dominantpredisposition for development of colorectal cancer (CRC) caused by germline defects in mismatch repair(MMR) genes. Current study was aimed to find genetic variations in MSH2 and MLH1 genes and theircorrelation with the serum levels of Carcinoembryonic Antigen (CEA) in seven Iranian HNPCC families.Seven unrelated Iranian families including 11 HNPCC patients and 7 affected family members were selected.They were initially screened for mutations in exons 7 of MSH2 and exon 15 of MLH1 gene throughpolymerase chain reaction single-strand conformation polymorphism (PCR-SSCP). Positive PCR results werefurther analyzed through exon sequencing. Serum CEA level was determined using the ELISA test. PCRSSCPwas positive in 8 out of 18 patients (44%) for exons 7 of MSH2 gene, whereas two samples (11%)demonstrated to bear a mutation in exon 15 of the MLH1 gene. Sequencing analysis of both amplified exonsin positive and negative samples have confirmed no mutation in negative samples while revealed 5 and 7novel mutations in exons 7 and 15, respectively. The mean serum concentration of CEA had a significantdifference between HNPCC patients and their healthy family members. Our results demonstrated that thePCR-SSCP method has high specificity and sensitivity in the first step of mutation screening of HNPCCfamilies. High frequency of novel alterations found in the current assay may revise the mutation screening ofMSH2 and MLH1 genes and abet further assessment of their frequency among individual HNPCC patients.
机译:遗传性非息肉病结直肠癌(HNPCC)是最常见的常染色体多种致癌癌症(CRC)的常规显性癌症(CRC),由不匹配修复(MMR)基因中的种系缺陷引起。目前的研究旨在发现MSH2和MLH1基因的遗传变异,七个伊朗HNPCC系列中的血清水平的癌症水平癌症抗原(CEA)。在其中选择11例HNPCC患者和7名受影响的家庭成员,包括11例HNPCC患者,最初是最初的筛选MSH2的外显子7和MLH1基因的外显子15的突变通过聚合酶链反应单链构象多态性(PCR-SSCP)。通过外显子测序分析阳性PCR结果。使用ELISA测试测定血清CEA水平。 PCRSSCPWAS在18名患者中有8例(44%),用于MSH2基因7的外显子7,而两种样品(11%)证明在MLH1基因的外显子15中承受突变。扩增的外虫阳性和阴性样品的测序分析已经证实了阴性样品中的突变,同时揭示了外显子7和15中的5和7诺叶突变。 CEA的平均血清浓度在HNPCC患者及其健康的家庭成员之间具有显着性。我们的研究结果表明,HNPCCFamilies的突变筛选的第一步中具有高特异性和敏感性。在当前测定中发现的新型改变的高频率可以修改MSH2和MLH1基因的突变筛选,并在个体HNPCC患者中进一步评估它们的频率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号